Selank Peptide: Regulatory Status and Evidence

Selank is a synthetic peptide. It is not an FDA-approved drug. This page explains its research status and the limits of the evidence, rather than presenting it as an established treatment.

Selank peptide benefits: what does the evidence support?

Interest in Selank includes research into anxiety, memory and mood. Research interest is not proof of clinical benefit. Claims that it has no negative side effects or no addiction risk are not established by the evidence presented here and should not guide a treatment decision.

Safety and regulatory status

The FDA identifies potential immune-response and peptide-impurity concerns for compounded Selank acetate and says important human safety information is missing. A compounding policy or research listing is not FDA approval.

Read the FDA's assessment of Selank acetate.

Discussing peptide questions with a physician

An assessment should consider your symptoms, medical history, medicines and established treatment options. This educational page does not supply a dose, administration schedule or treatment protocol.

Epithalon (Epitalon): status and evidence · Contact the practice